Browsing Category

Supplier News

156 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

From DCAT Week 2024: Supplier News: Packaging 
By

By
A roundup of news from CDMOs/CMOs and suppliers in pharmaceutical packaging with news from Adare Pharma Solutions and ApiJect  * Adare Expanding Packaging & Warehouse Facilities in EU* ApiJect Expands…

From DCAT Week 2024: Supplier News: End-to-End: Drug Substances & Drug Products 
By

By
A roundup of news from CDMOs/CMOs with developments in both drug substances and drugs products featuring Lonza and Mabion. Highlights below.    * Lonza Expanding Conjugation Capacity; Adding Sterile Filling Line;…

From DCAT Week 2024: Supplier News: Formulation Development/Drug Product Manufacturing 
By

By
A roundup of news from CDMOs/CMOs in formulation development/drug product manufacturing from Alcami, Corealis Pharma, Curia, Delpharm and Grand River Aseptic Manufacturing. Highlights below.  * Alcami Expands Fill–Finish Mfg Capacity…

From DCAT Week 2024: Supplier News: Biologics Manufacturing 
By

By
A roundup of news from CDMOs/CMOs and suppliers in biomanufacturing, including advanced therapies, with news from Siegfried and Solvias. Highlights below.  * Siegfried Acquires Dinamiqs to Build a Cell- &…

From DCAT Week 2024: Supplier News: Chemicals/Chemical API Manufacturing 
By

By
The latest news for CDMOs/CMOs and suppliers involved in the development and manufacturing of chemicals and chemical active pharmaceutical ingredients (APIs) with news from Olon, Grace, PharmaBlock, Axplora, ChemCon, Suven…

Samsung Biologics Provides Update on Billion-Dollar-Plus Biomanufacturing Expansions 
By

By
Samsung Biologics is proceeding with a multi-billion-dollar-plus investment to expand its biomanufacturing capacity, which includes the addition of new biomanufacturing plant in South Korea. The company’s expansion news was outlined…

Thermo Fisher Scientific Highlights Multiple Expansions: Sterile Drug-Product & Biologics Mfg 
By

By
Thermo Fisher Scientific is advancing several expansions, including in biologic drug-substance and sterile drug-product manufacturing. Jennifer Cannon, President, Commercial Operations, Pharma Services, Thermo Fisher Scientific, provided an update at the…

Noramco Updates Integration of Acquisition of Cambrex’s Drug-Product Business  
By

By
Normaco, a CDMO of small-molecule active pharmaceutical ingredients (APIs), recently added drug-product capabilities with the acquisition of the drug-product business of Cambrex. Bill Grubb, Vice President, Corporate Development, Noramco, provided…

Simtra BioPharma Solutions Announces $250-M  Expansion of Sterile Fill-Finish Mfg Campus 
By

By
Simtra BioPharma Solutions is investing $250 million-plus to expand its sterile fill-finish manufacturing campus. Franco Negron, CEO, Simtra BioPharma Solutions, outlined the expansion at the DCAT Member Company Announcement Forum…

Fujifilm Diosynth Biotechnologies Updates Multi-Billion-Dollar Biomanufacturing Expansions  
By

By
Fujifilm Diosynth Biotechnologies is proceeding with a multi-billion-dollar biomanufacturing expansion. Lars Petersen, President & CEO, Fujifilm Diosynth Biotechnologies, provided an update at the DCAT Member Company Announcement Forum held on…